GSK Soothes Investors By Settling First Zantac Cancer Lawsuit Due For US Trial
By Natalie Grover and Eva Mathews (Reuters) -GSK agreed to settle a U.S. lawsuit alleging its discontinued heartburn drug Zantac caused cancer, the British drugmaker said on Friday, preventing the first such case from going to trial next month. The company said it had reached a confidential deal with Californian resident James Goetz who says…
